Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma

• Published in: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy Vol. 281; p. 121625
• Main Authors: Ramzy, Sherif, Abdelazim, Ahmed H., Osman, Ayman OE, Hasan, Mohamed A.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 15.11.2022
• Subjects: COVID-19; Favipiravir; Hydroxychloroquine; Remdesivir; Synchronous fluorescence spectroscopy; COVID-19; Remdesivir; Synchronous fluorescence spectroscopy; Hydroxychloroquine; Favipiravir
• ISSN: 1386-1425
• DOI: 10.1016/j.saa.2022.121625

[Display omitted] •Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine.•Fluorescence spectra of favipiravir, remdesivir and hydroxychloroquine shows severe overlap.•Quantitative analysis in the spiked human plasma. Favipiravir, remdesivir and hydroxychloroquine have been suggested in COVID-19 Treatment Guidelines Panel of many countries. Synchronous spectrofluorometric measurement provides sensitive tool for resolving the overlapped spectra of multicomponent drugs through converting the wider spectra to narrower sharp spectra. This work introduces the first fluorescence spectroscopic method for quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma. Testing the fluorescence spectra of favipiravir, remdesivir and hydroxychloroquine shows severe overlap, which hinders the direct quantification of the cited drugs. To overcome the overlapping issue, the drugs under the study have been measured in the synchronous mode at Δλ = 60 nm. Favipiravir could be measured directly at 423 nm without interference of remdesivir or hydroxychloroquine. Synchronous measuring the cited drugs at Δλ = 130 nm with mathematical transforming to the first order derivative spectra allowing remdesivir and hydroxychloroquine at 384 nm and 394 nm, respectively without interference from favipiravir. Different factors affecting the spectrofluorometric measurement process have been verified. The drugs under the study have been successfully quantitatively analyzed in the spiked plasma using the proposed method.